Compounded topical finasteride products, lacking FDA approval, have been associated with persistent adverse effects, including sexual dysfunction and mood disturbances, even after discontinuation. Reports highlight risks such as erectile dysfunction, decreased libido, anxiety, and depression, which may persist after use. Healthcare professionals should counsel patients about potential risks and are reminded to report adverse events to the FDA MedWatch program.

Source: FDA